Florian Grebien joins LBI-CR as team leader to develop his independent research programme in acute myeloid leukemia (AML) in January 2014.
He completed his postdoctoral research in the team of Giulio Superti-Furga at the Research Centre for Molecular Medicine and will continue his outstanding research to elucidate the mechanistic basis of leukemogenesis.His team will be using a multidisciplinary approach, deploying a number of modern techniques, including shRNA and drug screening, expression profiling and proteomics. Within the forthcoming years, Dr. Grebien will develop a strong independent research team with international visibility, benefitting from the full support of the LBI-CR and the stimulating research environment provided by the LBI-CR's partner institutions. With this appointment the LBI-CR creates an attractive opportunity for an outstanding Austrian young research talent with the support of the LBG .
Please see the career section for current recruitments of the Grebien team.